Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew J Nunn
Patrick P J Phillips

Showing results (1-10 of 143) with videos related to

Pageof 15
Sort By:
Future Medicinal Chemistry|March 24, 2011
Challenges of Phase III study design for trials of new drug regimens for the treatment of TBPatrick P J Phillips, Andrew J Nunn
Plos One|May 14, 2013
An evaluation of culture results during treatment for tuberculosis as surrogate endpoints for treatment failure and relapsePatrick P J Phillips, Katherine Fielding, Andrew J Nunn
Tuberculosis (Edinburgh, Scotland)|October 10, 2008
Design issues in pivotal drug trials for drug sensitive tuberculosis (TB)Andrew J Nunn, Patrick P J Phillips, Stephen H Gillespie
Clinical Trials (London, England)|July 17, 2012
When inferiority meets non-inferiority: implications for interim analysesDaniel J Bratton, Hywel C Williams, Brennan C Kahan, et al.
Plos Medicine|March 23, 2019
Keeping phase III tuberculosis trials relevant: Adapting to a rapidly changing landscapePatrick P J Phillips, Carole D Mitnick, James D Neaton, et al.
BMC Medicine|November 25, 2017
A comparison of liquid and solid culture for determining relapse and durable cure in phase III TB trials for new regimensPatrick P J Phillips, Carl M Mendel, Andrew J Nunn, et al.
BMC Medicine|February 6, 2016
Limited role of culture conversion for decision-making in individual patient care and for advancing novel regimens to confirmatory clinical trialsPatrick P J Phillips, Carl M Mendel, Divan A Burger, et al.
Trials|September 10, 2014
Evaluation of a standardized treatment regimen of anti-tuberculosis drugs for patients with multi-drug-resistant tuberculosis (STREAM): study protocol for a randomized controlled trialAndrew J Nunn, I D Rusen, Armand Van Deun, et al.
The New England Journal of Medicine|September 9, 2014
Four-month moxifloxacin-based regimens for drug-sensitive tuberculosisStephen H Gillespie, Angela M Crook, Timothy D McHugh, et al.
Antimicrobial Agents and Chemotherapy|June 30, 2010
Impact of cotrimoxazole on carriage and antibiotic resistance of Streptococcus pneumoniae and Haemophilus influenzae in HIV-infected children in ZambiaDarlington M Mwenya, Bambos M Charalambous, Patrick P J Phillips, et al.
Pageof 15

Showing results (1-10 of 143) with videos related to

Sort By:
Pageof 15
Future Medicinal Chemistry|March 24, 2011
Challenges of Phase III study design for trials of new drug regimens for the treatment of TBPatrick P J Phillips, Andrew J Nunn
Plos One|May 14, 2013
An evaluation of culture results during treatment for tuberculosis as surrogate endpoints for treatment failure and relapsePatrick P J Phillips, Katherine Fielding, Andrew J Nunn
Tuberculosis (Edinburgh, Scotland)|October 10, 2008
Design issues in pivotal drug trials for drug sensitive tuberculosis (TB)Andrew J Nunn, Patrick P J Phillips, Stephen H Gillespie
Clinical Trials (London, England)|July 17, 2012
When inferiority meets non-inferiority: implications for interim analysesDaniel J Bratton, Hywel C Williams, Brennan C Kahan, et al.
Plos Medicine|March 23, 2019
Keeping phase III tuberculosis trials relevant: Adapting to a rapidly changing landscapePatrick P J Phillips, Carole D Mitnick, James D Neaton, et al.
BMC Medicine|November 25, 2017
A comparison of liquid and solid culture for determining relapse and durable cure in phase III TB trials for new regimensPatrick P J Phillips, Carl M Mendel, Andrew J Nunn, et al.
BMC Medicine|February 6, 2016
Limited role of culture conversion for decision-making in individual patient care and for advancing novel regimens to confirmatory clinical trialsPatrick P J Phillips, Carl M Mendel, Divan A Burger, et al.
Trials|September 10, 2014
Evaluation of a standardized treatment regimen of anti-tuberculosis drugs for patients with multi-drug-resistant tuberculosis (STREAM): study protocol for a randomized controlled trialAndrew J Nunn, I D Rusen, Armand Van Deun, et al.
The New England Journal of Medicine|September 9, 2014
Four-month moxifloxacin-based regimens for drug-sensitive tuberculosisStephen H Gillespie, Angela M Crook, Timothy D McHugh, et al.
Antimicrobial Agents and Chemotherapy|June 30, 2010
Impact of cotrimoxazole on carriage and antibiotic resistance of Streptococcus pneumoniae and Haemophilus influenzae in HIV-infected children in ZambiaDarlington M Mwenya, Bambos M Charalambous, Patrick P J Phillips, et al.
Pageof 15